Reacción #1100118

ord-f535ae210fb44ff6bbc5d3b351e7c30b

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    workup.STIRRINGstirring
  2. 2
    workup.WAITcontinued for 1 h
  3. 3
    OtroThe reaction mixture was partitioned between DCM and NH4OH
  4. 4
    SecadoThe organic layer was dried over MgSO4
  5. 5
    Concentraciónconcentrated under reduced pressure
  6. 6
    OtroPurification
  7. 7
    Otroby chromatography (EtOAc/MeOH 9:1 +1% NH4OH) and crystallisation from ether

Procedimiento

trans-4-(4-methoxy-benzothiazol-2-yloxy)-cyclohexylamine (0.5 mmol, intermediate 25.b) and 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazine-6-carbaldehyde (0.5 mmol) were dissolved in DCE (4 ml) and MeOH (4 ml). The mixture was stirred at RT overnight, NaBH4 (1 eq) was added and stirring continued for 1 h. The reaction mixture was partitioned between DCM and NH4OH. The organic layer was dried over MgSO4 and concentrated under reduced pressure. Purification by chromatography (EtOAc/MeOH 9:1 +1% NH4OH) and crystallisation from ether gave 36 mg (16%) of the title compound as a colourless solid.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07981886B2uspto-grants-2011_07